Slashdot Mirror


First Anti-Cancer Nanoparticle Trial On Humans a Success

An anonymous reader writes "Nanoparticles have been able to disable cancerous cells in living human bodies for the first time. The results are perfect so far, killing tumors with no side effects whatsoever. Mark Davis, project leader at CalTech, says that 'it sneaks in, evades the immune system, delivers the siRNA, and the disassembled components exit out.' Truly amazing."

64 of 260 comments (clear)

  1. Re:Finally.. by McGiraf · · Score: 5, Funny

    ... to start smoking ....

  2. Targetting by oldhack · · Score: 2, Interesting

    How do they direct them into tumor cells?

    --
    Fuck systemd. Fuck Redhat. Fuck Soylent, too. Wait, scratch the last one.
    1. Re:Targetting by alexborges · · Score: 4, Insightful

      They have RNA that attaches to cancerous and only cancerous cells. Of course, there are types of cancer that wont "bind" with this thingies, but supposedly, if I remeber correctly, they are the rarest.

      --
      NO SIG
    2. Re:Targetting by reverseengineer · · Score: 5, Informative

      The nanoparticles have a component that attaches to the transferrin receptor on the surface of a cancer cell. Transferrin receptors are highly abundant on cancer cells because iron (what transferrin carries) is needed for cell division processes. Coincidentally, this is a fact I learned the first time this story was posted a few days ago.

      --
      "FDA staff reviewers expressed concern about the number of patients who were left out of the study because they died."
    3. Re:Targetting by Kral_Blbec · · Score: 4, Informative

      Incorrect. There are significant physiological and genetic differences between cancerous cells and normal cells. It would be entirely possible to target the RNA sequence to only bind to malignant cells and ignore normal ones.

    4. Re:Targetting by Edmund+Blackadder · · Score: 3, Informative

      I see your point that this does not seem like the ordinary concept of targeting. But in pharmacology that is exactly what targeting is.

    5. Re:Targetting by cortesoft · · Score: 5, Informative

      How else would you define targeting in this context other than to mean only binding to cancerous cells? It seems you are implying that targeting can only refer to conscious 'aiming', but that is only a subset of things that can be considered targeted.

      Targeted can mean 'select as an object of attention or attack'. That is what they are doing when the design a drug.. selecting cancer cells for attack, and then designing the drug so it will only effect those cells. Check out http://en.wikipedia.org/wiki/Drug_design

      Targeted drugs DO mean something specific in pharmacology.

    6. Re:Targetting by wisty · · Score: 2, Interesting

      I'd guess that normal cells don't have as many, because they don't replicate as fast. But some fast-replicating cells (hair, some blood cells, etc) might have a few. Note, chemo also targets fast-replicating cells, which is why it kills cancer and makes your hair fall out.

      So this would be a suped-up chemo treatment, and hopefully a bit more specific.

    7. Re:Targetting by icannotthinkofaname · · Score: 5, Funny

      Great post. But please, can we stop using effect as a verb?

      No. We only need to effect such a change such that people stop using the verb "to effect" incorrectly.

      --
      Let q be a radix > 1. I am in ur base-q, killing 10 d00ds.
    8. Re:Targetting by MichaelSmith · · Score: 3, Interesting

      Incorrect. There are significant physiological and genetic differences between cancerous cells and normal cells. It would be entirely possible to target the RNA sequence to only bind to malignant cells and ignore normal ones.

      Yeah but chemotherapy and radiotherapy work the same way. The problem is that the characteristic of cancerous cells they bind to is the fact that they grow fast. The problem is that these treatments also damage normally fast growing tissues. My father in law lost all his bone marrow that way.

      I hope that these nanoparticles don't bind to any other crucial tissues.

    9. Re:Targetting by ShooterNeo · · Score: 2, Informative

      Yes but the beauty of this treatment is that it's two stage. Once the RNA gets into a cell, it can be targeted to ONLY harm cells with the RNAs of cancer floating around in their cytoplasms.

    10. Re:Targetting by cmiller173 · · Score: 2, Insightful

      Because if the tumor has metastasized there may be lots of tiny undetectable tumors else/everywhere in the body.

    11. Re:Targetting by amRadioHed · · Score: 4, Informative

      Well, the summary says that the results have been perfect so far, so that's a real good sign. Frankly something like this sounds too good to be true, but every once and a while breakthroughs do happen, so we can hope!

      --
      We hope your rules and wisdom choke you / Now we are one in everlasting peace
    12. Re:Targetting by wickerprints · · Score: 4, Informative

      Why is this the first example of the concentration of nanoparticles showing a correlation with the initial dose? To me it seems obvious that this would happen, so I'm curious as to what normally prevents this.

      The dose-response characteristics of a substance carries important information about its pharmacokinetics, such as how rapidly it is metabolized and excreted. It is NOT obvious that increasing dose always results in increased concentration in the targeted tissue(s), just as it is the case in chemical reactions in which increasing the proportion of one reagent may not necessarily increase the yield. For example, increasing dosage may also increase hepatic clearance. What the researchers demonstrated basically boils down to this: the nanoparticles' activity is highly specific to the tumor cells and does not get "broken down" or excreted proportionally higher as the dose increases. Such characteristics are highly desirable.

    13. Re:Targetting by interkin3tic · · Score: 4, Informative

      It would be entirely possible to target the RNA sequence to only bind to malignant cells and ignore normal ones.

      Yeah but chemotherapy and radiotherapy work the same way. The problem is that the characteristic of cancerous cells they bind to is the fact that they grow fast.

      No they don't work the same way. Radiotherapy, and most current gen chemotheraputics, work against all dividing cells. It sounds like these nanoparticles use a specific protein (NOT rna) to bind to the cancer cell, then once inside they cause RNAi (this is where the RNA comes in) to knock down a specific gene transcript.

      I obviously don't know the specifics, but if you make a nanoparticle that binds to and is taken up by cells expressing a specific growth factor, that's -not- going to be taken up by all cells. There are a lot of growth factors, and often in cancers, growth factor receptors are expressed far more than they normally are. So the targets are found only on some cell types, and there are hundreds more on the cancer cells than the healthy cells.

      Furthermore, you could target individual genes to be knocked down by the RNAi effect, potentially genes that aren't even expressed by the normal cells which are expressing the receptor you're targeting. I'd guess for maximal efficiency, you'd be targeting housekeeping genes that all cells needed, but in principle you could make it a gene that cancer specifically needed.

      Both levels of specificity, even if they're not used, are a far cry from "damage every dividing cell and hope you kill the cancer before you kill the dividing tissues the patient needs to survive." And they don't actually use RNA to bind to the cell, they use protein to target the cell and RNA once inside the cell to target the specific gene. ... by the way, I am not a molecular cancer biologist.

    14. Re:Targetting by reverseengineer · · Score: 2, Informative

      Yes, normal cells could be expected to have a smaller density of transferrin receptors than cancer cells, but almost all cells could be expected to have some, given the importance of iron ions in cells. The reason transferrin receptors are of such interest is primarily a mechanical issue. Each of your cells is covered with complicated receptors that serve many purposes, and if you're looking for a way for cancer cells to stand out, there are many receptors involved in growth and division whose numbers are typically swollen on cancer cells. The issue is that most of the candidates simply meet messengers at the cell membrane, and pass along the information of the message into the cell via a second messenger. Others like the glucose transporters let cargo through a narrow and specific channel. When transferrin receptors bind to transferrin at the cell surface, however, a vesicle forms around the bound transferrin+receptor complex and pulls the whole thing inside the cell. Once deep inside, the transferrin is induced to let go of its iron ion cargo, and the iron-less complex heads back to the surface. Given that cells will essentially swallow anything that can be made to bind to a transferrin receptor, this could become an important future route for drug delivery.

      However, yes, it is like chemotherapy in that it will affect proliferating healthy cells as well as cancer cells (could be a lot less toxic in terms of metabolic clearance compared to current oncolytics). The protein they cut production on using RNA interference, ribonucleotide reductase, is already targeted by a few chemo drugs in use like gemcitabine. Any cell that needs to make DNA bases needs a working copy of ribonucleotide reductase; rapidly dividing cancer cells just have a much more urgent need. However, this nanoparticle/siRNA system has the advantage of being highly adaptable. Find a new oncogene target? Write a new siRNA to silence it, and you have the equivalent of a whole new class of cancer drug.

      --
      "FDA staff reviewers expressed concern about the number of patients who were left out of the study because they died."
  3. Re:CmdrTaco's hung like a toddler by binarylarry · · Score: 3, Insightful

    This is science, not magic.

    --
    Mod me down, my New Earth Global Warmingist friends!
  4. Re:Too small a sample size by RyuuzakiTetsuya · · Score: 4, Informative

    Well, what's meaningful is that they all didn't up and die, and that a bigger round of testing is to go forward.

    --
    Non impediti ratione cogitationus.
  5. Re:Too small a sample size by Truth+is+life · · Score: 4, Informative

    The point of the study is to make sure that people don't explode when the procedure is performed, or for something similarly unpleasant to happen--it's a Phase I study, not a real effectiveness trial.

  6. Not just cancer! by Nihiltres · · Score: 5, Informative

    From comments on TFA, "The Lab" writes: "a science editor would be more capable of pointing out what is really exciting here, which is the ability to stop cells from producing a given protein."

    I think the cancer aspect is great (if it works) but this has potential for curing a whole host of diseases.

    Now we just need to figure out how to change people's DNA on the fly.

    1. Re:Not just cancer! by Anonymous Coward · · Score: 2, Funny

      Whoa slow down there. Do you know how long it'll take to patent the treatment for each individual disease?

    2. Re:Not just cancer! by wizardforce · · Score: 4, Interesting

      RNAi is an ancient anti-viral defense mechanism found in everything from plants to humans. That said, I agree. Any disease that is caused by the production of a given protein could in principle be treated using a derivative of this RNAi nanoparticle technology.
       

      Now we just need to figure out how to change people's DNA on the fly

      Viruses come close to this, it is just a matter of expanding what they can do (eg. enlarging their payload) and reducing the incidence of side effects like severe immune reactions.

      --
      Sigs are too short to say anything truly profound so read the above post instead.
  7. Re:Too small a sample size by Barny · · Score: 5, Insightful

    Not to mention there are now at least 15 extremely happy people out there :)

    --
    ...
    /me sighs
  8. Nice if true by nysus · · Score: 2, Insightful

    Gizmodo? Call me when a reputable publication reports on this.

    --

    ---Technology will liberate us if it doesn't enslave us first.

    1. Re:Nice if true by ColdWetDog · · Score: 2, Insightful

      Gizmodo? Call me when a reputable publication reports on this.

      Does Slashdot count?

      --
      Faster! Faster! Faster would be better!
    2. Re:Nice if true by spud603 · · Score: 5, Informative

      How about Nature?

    3. Re:Nice if true by MobileTatsu-NJG · · Score: 4, Funny

      Gizmodo? Call me when a reputable publication reports on this.

      You came to Slashdot because Gizmodo isn't a reputable publication? Hehehe.

      --

      "I like to lick butts!" by MobileTatsu-NJG (#32700246) (Score:5, Informative)

    4. Re:Nice if true by raddan · · Score: 4, Funny

      What, those hippies? I want something Fair and Balanced!

  9. Re:Finally.. by moteyalpha · · Score: 4, Funny

    Well I can finally go to California, everything is known to cause cancer in California,
    Or "its known to the State of California to cause cancer".
    I could never figure it out, so I just stay away from California.

  10. Someone call Dr. Imakurusu by Dachannien · · Score: 2, Funny

    Nanotechnology, huh?

    And here I had all my money on the Murai vaccine.

  11. Then take a statistics class by Anonymous Coward · · Score: 4, Informative

    As long as the subjects have the same distribution as the population, this sample can be considered representative of the population. This means that they didn't pick 15 terminal patients and didn't pick 15 100%-survival-rate patients. You can achieve quite a lot when your sample is well selected.

    1. Re:Then take a statistics class by BitZtream · · Score: 2, Informative

      Self reply ...

      I just feel I should clarify, in order to get the perfect distribution you need a sample size at least big enough to all possible variations in the distribution in the ratios present in the population.

      I.E. The samples too small to provide useful statistical results. Its just a general indicator.

      If all 15 people live perfectly for a normal life after this it doesn't mean its 100% safe, it just means its highly likely to work well on a lot of people, but its entirely possible that those 15 people happened to share something that no one else has. Likewise if all 15 people die tomorrow, its a really good indication that this isn't going to be that useful on the population, but it doesn't mean that everyone will die from it ... those 15 people may just have been exposed to a secondary compound since they are all early test subjects that happened to interact and kill them.

      The sample size is just too small to provide truely useful stats when it represents about 4 bits of diversity in a population that is defined by a code that allows for 38 bits of variation currently representing about 33.5 bits of that.

      Its funny how engineers like to over sample. An engineer wouldn't accept a sample size less than 39 bits to be safe, even though the total population is smaller than that currently. Statisticians on the other hand are happy with pretty much any number greater than 1 bit.

      --
      Persistent Volume manager for Kubernetes - https://github.com/dwimsey/openshift-pvmanager
  12. SWEET SUCCESS by OrwellianLurker · · Score: 2, Interesting

    Can we now laugh at all that silliness that smoking cigarettes leads to death? I can't wait till Camel gets in on the cancer killin' business.

    --
    'Political power grows out of the barrel of a gun.' - Mao Tse-tung
    1. Re:SWEET SUCCESS by subanark · · Score: 5, Funny

      1. Start smoking, paying $$$ for cigs
      2. Get cancer
      3. Pay $$$ for an operation to remove cancer cells
      4. ???
      5. Profit ?!?

    2. Re:SWEET SUCCESS by NigelTheFrog · · Score: 3, Informative

      Too bad this won't do anything for emphysema.

    3. Re:SWEET SUCCESS by Statecraftsman · · Score: 4, Funny

      Camel Lights, now with siRNA Nanoparticles!

  13. Re:Too small a sample size by chowdahhead · · Score: 5, Insightful

    It's a phase-I trial, it only confirms safety already established in animal models and kinetics. Phase-II and phase-III trials, much larger in scale, assess efficacy and optimum dosing. That will tell us if this can be more effective than traditional chemotherapy (possible) and monoclonal chemotherapy (much more difficult to predict).

  14. Hooray! by Eggplant62 · · Score: 2, Insightful

    This is so much win, I can hardly stand it. And I never thought I'd see the day when they'd be able to find something to kill this cancer trash. We all live in very interesting times.

  15. Re:Artificial virus by gujo-odori · · Score: 4, Funny

    All that will accomplish is to fill the world with beautiful, bisexual nympho women who still aren't interested in you...

  16. Re:Too small a sample size by brianleb321 · · Score: 5, Informative

    I cannot see anything meaningful coming from such a small sample size. It has potential but obviously much more research is needed.

    You can't just jump from rats to tens of thousands of humans. That's why the sample size is 15. That's why it's a Phase I trial. There are four phases of clinical pharmaceutical testing that follow preclinical (animals, in vitro, etc.) testing. Phase I normally tests a treatment in healthy humans in order to see the negative effects of the treatment (this is not necessarily the case in cancer treatments because all cancer treatments have significant negative effects). Phase I trials are only a couple dozen people, max. Successful Phase I trials allow for Phase II trials. These usually have one or two hundred people with the disease the therapy is intended to treat. In Phase II, they are mainly gathering pharmacokinetic data (half life, metabolism, volume of distribution, etc.). Phase III is where you start to see the trials you're clamoring for. These are typically done in several thousand patients, all with the disease in question. These trials are placebo-controlled, randomized, double-blind studies (the hallmark of research). Statistical analysis then allows you to determine if the therapy was effective in improving outcomes. If so, the drug goes to the FDA. 30 days later, it is officially on the market. Phase IV studies begin here, and continue perpetually. They are called post-marketing surveillance, and they study long-term effects (because previous trials are not long enough to do this), as well as very rare adverse effects (where the sample size in previous trials may have been too small to correctly detect the progressive multifocal leukoencephalopathy that occurs in 0.1% of patients treated).

    So don't claim the study size wasn't big enough - it wasn't supposed to be. Phase III trials are what you want. Phase I and II trials are of no interest to anyone outside of health professions, really.

    --
    Please stop pluralizing words with an apostrophe. That is not what it is there for.
  17. Re:Isn't this... by newcastlejon · · Score: 5, Funny

    Of course they do: ENHANCE!

    --
    If God forks the Universe every time you roll a die, he'd better have a damned good memory.
  18. Re:Isn't this... by Trebawa · · Score: 2, Informative

    You'd have to engineer particles that target a specific vital tissue (and stop thinking "brain", because the blood-brain barrier would block that), and then deliver a piece of siRNA that silences an essential gene for that tissue. You'd also have to inject enough of these into the person to have this effect. Still, it could be useful to replace the siRNA entirely with some kind of toxin (it would be nearly undetectable, because it wouldn't linger in the bloodstream).

  19. Who cares? by Weaselmancer · · Score: 3, Insightful

    Who cares how the particles get inside the cancer cells? Does it matter if we use microscopic needles and inject every single cancer cell or just throw a bunch of square pegs at square holes and hope for the best?

    The end result is that the medicine winds up where it should be, and doesn't seem to be accumulating where it shouldn't.

    BTW, in the above referenced Nature article it says this:

    When the components are mixed together in water, they assemble into particles about 70 nanometres in diameter. The researchers can then administer the nanoparticles into the bloodstream of patients, where the particles circulate until they encounter 'leaky' blood vessels that supply the tumours with blood. The particles then pass through the vessels to the tumour, where they bind to the cell and are then absorbed.

    So maybe that counts as targeted. Maybe not. I don't care either way - it works, regardless of semantics.

    --
    Weaselmancer
    rediculous.
  20. Re:Finally.. by countertrolling · · Score: 2, Funny

    ...everything is known to cause cancer in California...

    Are you saying that this nano thingy will consume the whole state?

    --
    For justice, we must go to Don Corleone
  21. Re:The good.. and bad? by DigiShaman · · Score: 2

    Could come in the water supply along with fluoride you already get. Maybe not in the USA, but some nation on this planet will think it's a good idea.

    Politicians get special bottled water to enhance their genome however.

    --
    Life is not for the lazy.
  22. damn it... by alobar72 · · Score: 2, Funny

    I quit yesterday :-(

  23. The first? Hardly... by QuietLagoon · · Score: 2, Informative
    Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. The Abraxis portfolio includes the world's first and only protein-based nanoparticle chemotherapeutic compound (ABRAXANE) which is based on its proprietary tumor targeting system known as the nab(TM) Technology platform. From the discovery and research phase to development and commercialization, Abraxis BioScience is committed to rapidly enriching the company's pipeline and accelerating the delivery of breakthrough therapies that will transform the lives of the patients who need them.

    .

    Abraxis has been around for, literally, years.

  24. Re:The good.. and bad? by Anarki2004 · · Score: 2

    That's what fluoride is for, silly!

    --
    The teachers will crack any minute, purple monkey dishwasher.
  25. That's because of a stupid law... by Oxford_Comma_Lover · · Score: 4, Informative

    > everything is known to cause cancer in California... I could never figure it out, so I just stay away from California.

    Everything says it causes cancer because of Proposition 65. Basically, if something in California is known to cause cancer (even only if ingested by the ton), you have to label it, or lawyers can sue you under a "private attorney general" law. In theory it might be a good idea, but it was implemented so that the defendant has the burden of showing that it's basically impossible to the nth degree that the thing could cause cancer in the quantities you're talking about.

    This resulted in a lot of litigation where basically lawyers went around everywhere and said "Oh! You have flame-retardant furniture! Did you know it can cause cancer if you lick it?" "You're a dentist! You use drugs that can cause cancer if you administer them for a week and you didn't post a notice!"

    This resulted in a plethora of notices to prevent lawsuits--notices which the public ignores because they're on everything. So in the cases where the warning is actually important, it gets ignored because there are so many.

    IIRC, there have been some efforts by the AG (and some courts) to limit abuse.

    --
    -- IANAL, this isn't legal advice, and definitely isn't legal advice for you. Also, Squee!
  26. Re:CmdrTaco's hung like a toddler by virtualXTC · · Score: 2, Insightful
    The problem with that quote is sufficiently advanced is a relative term with respect to a technologically evolved society. For example the a working light bulb would magic for a pre-electric society, but isn't all that magical now.

    This is science, not magic.

    "Any sufficiently advanced technology is indistinguishable from magic" - Arthur C. Clarke

  27. Hey, let's celebrate: by mcneely.mike · · Score: 2, Funny

    Break out the cuban cigars and pass me a diet Pepsi... sure you can smoke 'em if you got em! Cancer, smancer.... i eat urea formaldehyde foam insulation for breakfast!

    --
    soylentnews.org Go there to enjoy the people!
  28. Re:CmdrTaco's hung like a toddler by tzanger · · Score: 4, Funny

    Any technology which is distinguishable from magic is insufficiently advanced.

  29. Hopefully this works on Metastatic cancer by NotSoHeavyD3 · · Score: 2, Interesting

    Since currently if you have metastasis most of the time it's incurable.(If you're lucky you'll just be a chronic cancer victim.)

    --
    Did you know 80 to 90% of the moderators on slashdot wouldn't recognize a troll even if one dragged them under a bridge.
  30. It is spelled Caltech NOT CalTech by Gumby · · Score: 3, Informative

    http://media.caltech.edu/press_releases/13334

    If you cannot spell Caltech properly - please turn in your nerd card.

  31. Re:Too small a sample size by BenVis · · Score: 3, Interesting

    Thanks for the overview of the clinical trials procedure. You clearly know a lot about it. One thing I wanted to point out is that while placebo-controlled designs are probably the most reliable, in many contexts (including a cancer treatment) it would be unethical to give patients a placebo (i.e. a treatment expected to do nothing) rather than a treatment that might actually help them.

    Basically, if there is a treatment that is known to be at least somewhat effective, that's your control rather than a placebo. It might be that the definition of placebo has shifted to include any standard non-experimental treatment, but that would be news to me.

    --
    "Preceded by itself yields falsehood" preceded by itself yields falsehood.
  32. What could possibly go wrong? by spmkk · · Score: 2, Insightful

    "it sneaks in, evades the immune system..."

    Um, this doesn't catch anyone else as potentially really scary? What else might (now or eventually) sneak in and evade the immune system along with it?

    Not that it's relevant to anything, but Hollywood touched on this subject a few years ago.

  33. Re:Too small a sample size by Puff+of+Logic · · Score: 2, Informative

    Phase III trials in this situation would assess the efficacy of this treatment relative to the current standard of care. The whole point of phase III is to figure out whether the drug is at least as effective as the current standard and, as you correctly state, it would be medically unethical to administer a placebo treatment to a cancer patient.

    --
    P.P.S. I'm doing Science and I'm still alive.
  34. Immortality anyone? by Raystonn · · Score: 2, Interesting

    Wonderful. Now that we can destroy cancer cells, where can I sign up to have my telemeres refreshed? I'm not getting any younger here... yet.

  35. Re:FDA Approval? by Torvaun · · Score: 2, Insightful

    Hey, you really want to fight obesity, kill the corn subsidies so that we stop having high fructose corn syrup in fucking everything. That would be way more effective than unbanning ephedrine.

    --
    I see your informative link, and raise you a pithy comment.
  36. Re:This was already posted on /. 2 days ago! by Gumby · · Score: 2, Informative

    And that time they spelled Caltech correctly!

  37. Re:Isn't this... by c0mpliant · · Score: 3, Funny

    Sir, the man was killed by tiny Nano particles
    Hmmm, I guess...
    In the end...
    It is the little things that matter

    --
    There is no -1 disagree
  38. Re:The good.. and bad? by uncanny · · Score: 2, Funny

    it's got siRNA, it's what plants crave!

  39. Re:Artificial virus by Elbows · · Score: 3, Informative

    I didn't see any indication that the nano-particles are self-replicating, or capable of spreading from one person to another, so you'd need to inject each target individually. It's probably easier just to shoot them.

    Plus, if I understand correctly, cultural conceptions of race don't map very well to genetic differences. So finding a race-specific gene to target might be harder than you'd think.

  40. Re:Isn't this... by dougisfunny · · Score: 2, Funny
    --
    This is not the funny you're looking for.